MedPath

the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris

Phase 2
Conditions
Acne
Interventions
Registration Number
NCT00419848
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

a comparison of efficacy and adverse side effects occurrence of Doxycycline and Azithromycin in the management of moderate acne vulgaris

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Between 18 to 30 year old
  • Moderate facial Acne(At least 10 inflammatory lesions with maximum 3 nodules and pseudocysts
Exclusion Criteria
  • Pregnancy
  • Breast Feeding
  • Acne Fulminant
  • Acne conglobate
  • Isotretinoin therapy within past 6 months
  • topical treatment in last 2 weeks
  • use of systemic antibiotic in the last month
  • Hyperandrogenism symptoms
  • Menstrual irregularity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Azithromycin-
2Doxycycline-
Primary Outcome Measures
NameTimeMethod
change in acne lesions12 weeks
Secondary Outcome Measures
NameTimeMethod
global response rates, patient's own assessment, side effects and compliance12 weeks

Trial Locations

Locations (1)

Shaheed Beheshti Medical University, Skin research center

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath